Search results
Chronic Myelogenous Leukemia (CML): 5 Things to Know
Medscape· 4 days agoAdvanced and emerging therapies in CML offer significantly improved survival. These five things to know will help elucidate potential pitfalls and pearls...
...Expected to Reach USD 13.64 Billion by 2030 Predicts SNS Insider | Leading Companies – Abbott,...
Digital Journal· 12 hours agoThe global Type 1 Diabetes Market, which was valued at USD 7.59 billion in 2022, is anticipated to...
This biotech startup got the biggest venture capital deal in San Diego so far this year
U-T San Diego· 1 day agoSan Diego County recorded 55 venture capital deals totaling $1.57 billion in the first quarter...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 1 day agoThe company expects to begin a Phase 3 study in the second...in the same space — including Novartis,...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 1 week agoBig Growth Ahead: Biologic Drugs Market to Hit $823.4 Billion by 2028, Reveals BCC Research PR Newswire BOSTON, April 18, 2024 Biologic Therapeutic Drugs: Technologies and ...
Nucleic Acid-based Therapeutics Market to Reach USD 14.25 Billion by 2031 Driven by Surge in...
Digital Journal· 1 week agoThe demand for nucleic acid-based therapeutics has soared in recent years due to their effectiveness...
As more rare disease therapies launch, their prices are rising
Seeking Alpha· 1 week agoRare disease therapies are extremely expensive, with some costing millions of dollars. They are...
Which Probiotics Are Effective in Irritable Bowel Syndrome?
Medscape· 5 days agoIrritable bowel syndrome (IBS) is a common brain-gut axis disorder, and patients are often dissatisfied with conventional treatments. The role of the microbiota in IBS is ...
Her PAH Symptoms Were Getting Worse. Then She Joined a Clinical Trial
Healthline· 2 weeks agoPulmonary arterial hypertension (PAH) is a condition that causes a narrowing of the blood vessels in...
Neutral Result With Novel Agent in Diabetic Cardiomyopathy
Medscape· 2 weeks agoThe ARISE-HF trial testing aldose reductase inhibition in asymptomatic diabetic cardiomyopathy did not meet its endpoint but hints at a mechanism that might prevent it.